Marine algae are rich sources of various biologically active compounds with potential pharmaceutical properties. In the present study, we investigated the inhibitory effects of Plocamium telfairiae extract (PTE) on proinflammatory cytokine production in bone marrow-derived macrophage (BMDMs) and dendritic cells (BMDCs). PTE pre-treatment in LPS-stimulated BMDMs and BMDCs showed a strong inhibition on interleukin (IL)-12 p40, IL-6, and tumor necrosis factor (TNF)-α production as compared to non-treated controls. PTE pre-treatment showed significant inhibition on phosphorylation of mitogen-activated protein kinases and degradation of inhibitor of kappa B (IκBα). Taken together, these results suggest that PTE may have potential anti-inflammatory property and hence, warrant further studies concerning the potentials of PTE for medicinal purpose.
INTRODUCTION
Inflammation is the protective response of a host towards microbial infection or tissue damage (1, 2) . In acute inflammation, innate immune system plays an important role mediated by phagocytes together with dendritic cells and macrophages (3) . Pathogen associated molecular patterns (PAMPs), conserved in microorganisms, are recognized by pathogen recognition receptors (PRRs) such as Toll-like receptors (TLRs) (4, 5) .
Lipopolysaccharide (LPS), a bacterial endotoxin, is the potent microbial initiator of inflammation (6, 7) . Recognition of LPS by TLR4 activates mitogen-activated protein kinases (MAPKs) and nuclear factor kappa (NF-κB)-light-chain -enhancer of activated B cells resulting in the expression of proinflammatory cytokine genes (4) .
MAPKs belong to a large family of serine/threonine protein kinases which play a key role in cell survival/ apoptosis, proliferation, differentiation and inflammatory responses (8, 9) . Extracellular signal-regulated kinases (ERKs), c-jun N-terminal kinase (JNK) and p38 are the main classes of MAPKs. Inhibition of MAPKs such as ERK and JNK has been reported to prevent the production of proinflammatory cytokines (10). LPS plays a major role in pathogenesis of sepsis (endotoxic shock) by releasing 95 diverse range of proinflammatory mediators (11) . Suppression of proinflammatory cytokine overproduction may improve the survival in endotoxic shock (12) . Hence, therapies targeting inhibition of MAPKs and NF-κB might be effective in the treatment of inflammatory diseases such as sepsis.
Marine algae have been recognized as an important source of different minerals and bioactive compounds with potential pharmaceutical properties (13) . Plocamium telfairiae is a red alga which is distributed along the coastline of Korea. Methanolic extracts from P. telfairiae have been previously reported as chemopreventive or chemotherapeutic agent in colon carcinoma cells (14) . Moreover, P. telfairiae possess both lipophilic content and antioxidant capacity (15) . To the best of our knowledge, the present study is the first report on anti-inflammatory effect of Plocamium telfairiae extract (PTE) on primary murine BMDMs and BMDCs.
MATERIALS AND METHODS

Preparation of Plocamium telfairiae extract (PTE)
Plocamium telfairiae were collected on Jeju Island, Korea. The collected specimen has been deposited at the herbarium of Jeju Biodiversity Research Institute (JBRI).
The materials for extraction were cleaned, dried at room temperature for one week and ground into a fine powder.
The dried alga was extracted with 80% ethanol (EtOH; 2 ℓ) at room temperature for 24 h and then evaporated under a vacuum. P. telfairiae ethanol extract (PTE) was suspended in water (4 ℓ).
Mice
Six-week-old female C57BL/6 mice were purchased 
Cell cultures and measurement of cytokine production
To grow bone marrow-derived macrophage (BMDMs) and dendritic cells (BMDCs), wild-type six-week-old female C57BL/6 mice were used as previously described (16) .
Briefly, bone marrow cells were cultured in RPMI 1640 (BD, Grand Island, NY, USA) medium containing granulocytemacrophage colony-stimulating factor for dendritic cells. 
Cell viability assay
The cell viability was evaluated by standard procedure of 3-(4, 5-dimethyl-2, 5 thiazolyl)-2, 5 diphenyl tetrazolium bromide (MTT) assay (17) . Briefly, the cells were seeded at a density of 1 × 10 5 cells/0.5 ml in 48 well culture plates and incubated at 37℃, 5% CO 2 for 1 h. Then, cells
were treated with different concentrations of extract for 1 h, followed by stimulation with LPS (10 ng/ml) for 18 h. Then, 0.2 mg MTT (Sigma, MO, USA) was added to each well and the plates were incubated for 4 h at 37℃. The plate was centrifuged and the supernatants were removed, and the formazen crystals were dissolved with 250 μl dimethyl sulphoxide (DMSO) (Amresco, Solon, OH, USA). A wavelength of 540 nm was used to measure the absorbance.
Western blot analysis
This was performed using standard techniques as previously described (18) . In brief, BMDMs were dispensed immunoactive bands were detected as previously described (19) .
Data analysis
All experiments were performed at least three times, and the data are presented as mean ± standard deviation (SD).
One-way analysis of variance (ANOVA) was used for comparison between the treated and the control groups. p < 0.05 was considered statistically significant.
RESULTS AND DISCUSSION
Effects of PTE on cell viability in BMDMs and
BMDCs
To confirm the anti-inflammatory effects of PTE, colorimetric MTT assay was used for cell viability. The results showed little or no effect on cell viability of BMDMs (Fig. 1A) and BMDCs (Fig. 1B) until 25 μg/ml. Hence, we used non-toxic concentrations of PTE for further study.
Effects of PTE on the production of IL-12 p40, IL-6 and TNF-α in LPS-stimulated BMDMs and BMDCs
Dendritic cells and macrophages are the potent antigen presenting cells, involved in the production of proinflammatory cytokines such as IL-12 p40, IL-6 and TNF-α (20) . To determine anti-inflammatory activity of extract, PTE was examined for the inhibitory effects on LPSstimulated IL-12 p40, IL-6 and TNF-α production in BMDMs and BMDCs by using ELISA assay. Treatment of BMDMs and BMDCs with LPS alone resulted in significant production of IL-12 p40, IL-6 and TNF-α ( Fig. 2 and Fig. 3 ).
PTE pre-treatment showed strong inhibition of IL-12 p40, IL-6 and TNF-α production in LPS-stimulated BMDMs (Fig. 2) . Similarly, it strongly inhibited IL-12 p40, IL-6 and TNF-α production in LPS-stimulated BMDCs (Fig. 3) .
Hence, these results show that PTE has an inhibitory effect on proinflammatory cytokine production in LPS-stimulated However, overproduction of IL-6 is linked to inflammatory bowel disease (24) . In the present study, pre-treatment of PTE showed a strong inhibition of IL-6 production in LPS-stimulated BMDMs and BMDCs. So, down regulation of IL-6 production by PTE may have potentials in antiinflammatory diseases. TNF-α has a vital role in cell differentiation, apoptosis and immunoregulatory activities (25) . However, overproduction of TNF-α is associated with inflammatory disorders and sepsis (26, 27) . Here, PTE pretreatment showed significant inhibition of TNF-α production fore, we examined the effects of PTE on phosphorylation of MAPK and NF-κB activation in LPS-stimulated BMDMs by western blot analysis (Fig. 4) . Here, LPS stimulation of BMDMs significantly increased the phosphorylation of all three MAPKs; ERK1/2, JNK1/2 and p38. Phosphorylation of ERK1/2, JNK1/2 and p38 was detected between 15 to 30 min of LPS stimulation (Fig. 4A and B) . Phosphorylation of MAPK went back to baseline levels by 60 min of LPS stimulation. PTE pre-treatment showed inhibition of ERK1/ 2, JNK1/2 and p38 phosphorylation (Fig. 4A and B) .
NF-κB is an important transcription factor involved in the expression of various cytokines. Stimulation of cells by LPS leads to degradation of IκB and translocation of NF-κB into the nucleus (28, 29) . We studied the effects of PTE on NF-κB activation indirectly by degradation of IκBα in LPS-stimulated BMDMs. LPS was able to induce degradation of IκBα within 15 min of stimulation ( Fig. 4A and B). However, PTE pre-treatment blocked the IκBα degradation in LPS-stimulated BMDMs (Fig. 4A and B) .
Hence, these data show that PTE pre-treatment inhibited LPS-stimulated MAPK phosphorylation and NF-κB activation. Taken together, these results suggest that inhibition of pro-inflammatory cytokine production by PTE may be associated with blockage of MAPK and NF-κB activation.
In conclusion, this study indicates that PTE has an inhibitory effect on production of proinflammatory cytokines and TLR4-mediated MAPK and NF-κB activation. Further studies are warranted for detailed mode of actions of the pure biologically active compounds from PTE.
